remoxipride has been researched along with 3,4-dihydroxyphenylacetic acid in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (42.86) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gudelsky, GA; Nash, JF | 1 |
| Eaton, MJ; Lookingland, KJ; Moore, KE; Tian, Y | 1 |
| Fowler, CJ; Magnusson, O | 1 |
| Lake-Bakaar, DM; Magnusson, O; Mohringe, B; Thorell, G | 1 |
| Fowler, CJ; Magnusson, O; Mohringe, B | 1 |
| Georgieva, J; Magnusson, O; Mohringe, B | 1 |
| Cory-Slechta, DA; Reeves, R; Thiruchelvam, M | 1 |
7 other study(ies) available for remoxipride and 3,4-dihydroxyphenylacetic acid
| Article | Year |
|---|---|
Neuroendocrinological and neurochemical effects of sigma ligands.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzamides; Brain; Carbolines; Corticosterone; Dopamine; Dose-Response Relationship, Drug; Male; Median Eminence; Neurons; Prolactin; Pyridines; Pyrimidines; Rats; Rats, Inbred Strains; Receptors, Opioid; Receptors, sigma; Remoxipride; Spiro Compounds; Tyrosine 3-Monooxygenase | 1992 |
Remoxipride and raclopride differentially alter the activity of incertohypothalamic dopaminergic neurons.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Monoamines; Dopamine; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Hypothalamus; Male; Neurons; Raclopride; Rats; Remoxipride; Salicylamides | 1992 |
Comparison of the effects of the novel antipsychotic agent remoxipride on dopamine and noradrenaline turnover in the rat brain.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antipsychotic Agents; Benzamides; Brain Chemistry; Dopamine; Dose-Response Relationship, Drug; Homovanillic Acid; In Vitro Techniques; Male; Norepinephrine; Rats; Rats, Inbred Strains; Remoxipride; Tyrosine 3-Monooxygenase | 1989 |
Effects of the dopamine D2 selective receptor antagonist remoxipride on dopamine turnover in the rat brain after acute and repeated administration.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antipsychotic Agents; Benzamides; Body Weight; Brain Chemistry; Dopamine; Dose-Response Relationship, Drug; Female; Homovanillic Acid; Male; Rats; Rats, Inbred Strains; Receptors, Dopamine; Remoxipride | 1987 |
Comparison of the effects of dopamine D1 and D2 receptor antagonists on rat striatal, limbic and nigral dopamine synthesis and utilisation.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benzamides; Benzazepines; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Haloperidol; Homovanillic Acid; Male; Olfactory Bulb; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Remoxipride; Substantia Nigra; Sulpiride | 1987 |
Neurochemical effects of prolonged treatment with remoxipride as assessed by intracerebral microdialysis in freely moving rats.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemistry; Chromatography, High Pressure Liquid; Dopamine; Drug Tolerance; Homovanillic Acid; Infusion Pumps; Injections, Subcutaneous; Male; Microdialysis; Neostriatum; Rats; Rats, Sprague-Dawley; Remoxipride | 1994 |
Development of behavioral sensitization to the cocaine-like fungicide triadimefon is prevented by AMPA, NMDa, DA D1 but not DA D2 receptor antagonists.
Topics: 3,4-Dihydroxyphenylacetic Acid; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Behavior, Animal; Benzazepines; Brain Chemistry; Corpus Striatum; Drug Administration Schedule; Fungicides, Industrial; Male; Mice; Mice, Inbred C57BL; Motor Activity; N-Methylaspartate; Neuronal Plasticity; Piperazines; Quinoxalines; Receptors, AMPA; Receptors, Dopamine D1; Receptors, N-Methyl-D-Aspartate; Remoxipride; Substance Withdrawal Syndrome; Time Factors; Triazoles | 2004 |